You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activity
|
---|---|
Published in |
Journal of Translational Medicine, July 2010
|
DOI | 10.1186/1479-5876-8-71 |
Pubmed ID | |
Authors |
Chrystelle Brignone, Maya Gutierrez, Fawzia Mefti, Etienne Brain, Rosana Jarcau, Frédérique Cvitkovic, Nabil Bousetta, Jacques Medioni, Joseph Gligorov, Caroline Grygar, Manon Marcu, Frédéric Triebel |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 163 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Japan | 1 | <1% |
United States | 1 | <1% |
Canada | 1 | <1% |
Australia | 1 | <1% |
Unknown | 159 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 36 | 22% |
Student > Ph. D. Student | 28 | 17% |
Student > Bachelor | 16 | 10% |
Student > Master | 13 | 8% |
Student > Doctoral Student | 11 | 7% |
Other | 21 | 13% |
Unknown | 38 | 23% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 33 | 20% |
Agricultural and Biological Sciences | 27 | 17% |
Biochemistry, Genetics and Molecular Biology | 24 | 15% |
Immunology and Microbiology | 18 | 11% |
Pharmacology, Toxicology and Pharmaceutical Science | 8 | 5% |
Other | 12 | 7% |
Unknown | 41 | 25% |
Attention Score in Context
This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 August 2023.
All research outputs
#2,281,494
of 22,807,037 outputs
Outputs from Journal of Translational Medicine
#370
of 3,991 outputs
Outputs of similar age
#8,437
of 94,217 outputs
Outputs of similar age from Journal of Translational Medicine
#2
of 12 outputs
Altmetric has tracked 22,807,037 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,991 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.5. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 94,217 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 12 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 83% of its contemporaries.